Judge Won't Compel Boston Scientific Privileged Docs

Law360, New York (December 2, 2009, 6:12 PM EST) -- Plaintiffs in the ongoing consolidated securities fraud action against Boston Scientific Corp. have lost a bid to compel evidence related to the company’s internal investigation of a 2004 Taxus stent recall and other documents they claim should not be protected under attorney-client privilege.

Judge Douglas Woodlock of the U.S. District Court for the District of Massachusetts denied the motion to compel on Tuesday, arguing that the evidence at issue was protected by attorney-client privilege and the work product doctrine.

Lead plaintiff Mississippi Public Employees Retirement System...
To view the full article, register now.